Mizuho analyst Brett Linzey raised the firm’s price target on Emerson (EMR) to $173 from $155 and keeps an Outperform rating on the shares post the earnings report. The firm says secular trends are driving the company’s results with orders outperforming expectations. It cites higher peer valuations for the target boost.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EMR:
- Emerson price target raised to $191 from $165 at BofA
- Emerson price target raised to $168 from $164 at Baird
- Emerson price target raised to $174 from $165 at Citi
- Emerson price target raised to $160 from $145 at Wells Fargo
- Sell Rating Maintained Amid Growth Headwinds, Unreliable Order Signals, and Second-Half Execution Risks